Skip to main content

History and Development of Prostate Cryoablation

  • Chapter
  • First Online:
The History of Technologic Advancements in Urology
  • 916 Accesses

Abstract

Cryoablation is one of several therapeutic interventions that can result in thermal tissue destruction. This technique has well- documented scientific evidence supporting its efficacy as a treatment modality in the treatment of both benign and malignant diseases [1–3]. The operative mechanism produced by freezing is the extraction of heat from the targeted tissue that initiates a series of destructive events. The severity of the freezing process has long been recognized to result in a tissue response varying from inflammation to total destruction. Histologically freezing produces an area of central necrosis with a surrounding peripheral rim in which cell death is apparent [4, 5]. Successful tissue destruction resulting from cryoablation is founded on two scientific principles; first the cellular response to freezing itself and second to operative procedural factors. Freezing tissue induces cell death by setting off a cascade of events that include freeze rupture, necrosis and apoptosis. As ice forms in the targeted tissue, water is extracted from the extracellular space forming pure crystalline ice leaving behind hyperosmotic fluid in the extracellular compartment. As a consequence of this physical event, intracellular water moves to the extracellular space followed by cell shrinkage and damage to the intracellular matrix including proteins resulting from the increased salinity. In an anatomic constrained structure such as the prostate which is not totally encapsulated the expanding ice front and the spear-like ice crystals destroy both prostate cells and the capillary endothelial lining, the latter impairing the vascular tree after thawing [6]. In addition to the physical rupture of targeted tissue cells from the intracellular ice crystal formation apoptosis has been linked to thermal injury [7]. Hollister et al. have reported that after a freezing insult, prostate cancer cells die at temperatures consistent with the freeze-zone margin [8]. Induction of the apoptotic event is said to be associated with an intrinsic mitochondria induced mechanism characterized by the upregulation of cellular Bax, the pro-apoptotic protein [9]. More recently, prostate cancer cell apoptotic induction has been reported to be facilitated through an extrinsic pathway involving the interaction of tumor necrosis factor-related apoptosis-inducing ligand with its ligand in the plasma membrane [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Baust JG, Gage AA, Klossner D, Clark D, Miller R, Cohen J, et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat. 2007;6:97–109.

    Article  CAS  PubMed  Google Scholar 

  2. Gage AA, Baust JG. Cryosurgery of tumors. J Am Coll Surg. 2007;201:342–56.

    Article  Google Scholar 

  3. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60:40–9.

    Article  PubMed  Google Scholar 

  4. Gage AA, Baust J. Mechanism if tissue injury in cryosurgery. Cryobiology. 1998;37:171–86.

    Article  CAS  PubMed  Google Scholar 

  5. Larson TR, Robertson DW, Corcia A, Bostwich DG. In vivo interstitial temperature mapping of human prostate during cryosurgery with correlation to histopathologic outcomes. Urology. 2000;55(4):547–52.

    Article  CAS  PubMed  Google Scholar 

  6. Ayala AG, Ro JY, Babaian RJ, Troncoso P, Grignon D. The prostate capsule: does it exist? Its importance in staging and treatment of prostatic carcinoma. Am J Surg Pathol. 1989;13(1):21–7.

    Article  CAS  PubMed  Google Scholar 

  7. Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery – a putative approach to molecular-based optimization. Cryobiology. 2004;48:190–204.

    Article  CAS  PubMed  Google Scholar 

  8. Hollister WR, Mathew AJ, Baust JG, Van Buskirk RG. Effects of freezing on cell viability and mechanism of cell death in a human prostate cancer cell line. Mol Urol. 1998;2:13–8.

    Google Scholar 

  9. Clark K, Baust JM, Van Buskirk RG, Baust JG. Addition of anti-cancer agents enhancing freezing-induced prostate cancer cell death: implication of mitochondrial involvement. Cryobiology. 2004;49:45–61.

    Article  Google Scholar 

  10. Clark DM, Rubilitto AT, Van Buskirk RG, Baust JG, Gage AA, Baust JM. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(2):175–845.

    Article  Google Scholar 

  11. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 2005;95:1187–91.

    Article  PubMed  Google Scholar 

  12. Klossner DP, Baust JM, Van Buskirk RG, Gage AA, Baust JG. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int. 2008;101:1310–6.

    Article  CAS  PubMed  Google Scholar 

  13. Shinohara K, Connolly JA, Presti JC, Carroll PR. Cryosurgical treatment of prostate cancer (stages T1 to T4): preliminary results. J Urol. 1996;156:115–20.

    Article  CAS  PubMed  Google Scholar 

  14. Pisters LL v, Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997;157:921–5.

    Article  CAS  PubMed  Google Scholar 

  15. Schmidt JD, Doyle J, Larison S. Prostate cryoablation: update 1998. CA Cancer J Clin. 1998;48(4):239–53.

    Article  CAS  PubMed  Google Scholar 

  16. Arnott J. Practical illustrations of the remedial efficacy of a very low or anesthetic temperature. Lancet. 1850;2:257–9.

    Article  Google Scholar 

  17. White AC. Possibilities of liquid air to the physician. JAMA. 1901;36:426–8.

    Article  Google Scholar 

  18. Neel HB 3rd. Cryosurgery for the treatment of cancer. Laryngoscope. 1980;90:1–48.

    Article  PubMed  Google Scholar 

  19. Cooper IS, Lee A. Cryothalamectomy-hypothermic coagulation: a technical advance in basal ganglia surgery: preliminary report. J Am Geriatr Soc. 1961;9:714–8.

    Article  Google Scholar 

  20. Gonder MJ, Soanes WA, Smith V. Experimental prostate surgery. Investig Urol. 1964;1:610–9.

    CAS  Google Scholar 

  21. Flocks RH, Nelson CM, Boatman DL. Perineal cryosurgery for prostatic carcinoma. J Urol. 1972;108:933–5.

    Article  CAS  PubMed  Google Scholar 

  22. Gonder MJ, Soanes WA, Shulman S. Cryosurgical treatment of the prostate. Investig Urol. 1966;3:372–8.

    CAS  Google Scholar 

  23. Megali MR, Gursel EO, Veenema RJ. Closed perineal cryosurgery in prostate cancer. New probe and technique. Urology. 1974;4(2):220–2.

    Article  Google Scholar 

  24. Merry M, Smidebush M. Apparatus for cryosurgery. 1990. US Patent 4,946,460.

    Google Scholar 

  25. Rubinsky B, Onik G, Finkelstein JJ, Neu D, Jones S. Cryosurgical system for destroying tumors by freezing. 1994. US Patent 5,334,181.

    Google Scholar 

  26. Ando K. Cystoprostatectomy under control of ultrasono-tomagraphy. Presented at the 14th Congress of International Urologic Society. 1982.

    Google Scholar 

  27. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J. Transrectal ultrasound guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72:1291–9.

    Article  CAS  PubMed  Google Scholar 

  28. Levy DA, Ross AE, El Shafei A, Krishnan N, Hatem A, Jones JS. Definition of biochemical success following primary whole gland prostate cryoablation. J Urol. 2014;192(5):1380–4.

    Article  CAS  PubMed  Google Scholar 

  29. Roach M 3rd, Hank G, Thames H Jr, Shellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendation of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965–74.

    Article  PubMed  Google Scholar 

  30. Ellis DS. Cryosurgery as primary treatment for localized prostate cancer; a community experience. Urology. 2002;60(2 Suppl 1):34–9.

    Article  PubMed  Google Scholar 

  31. Shinohara K, Rhee B, Presti JC Jr, Carroll PR. Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol. 1997;158:2206–9.

    Article  CAS  PubMed  Google Scholar 

  32. Benoit RM, Cohen JK, Miller RJ Jr. Cryosurgery for prostate cancer: new technology and indications. Curr Urol Rep. 2000;1:41–7.

    Article  CAS  PubMed  Google Scholar 

  33. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from Cryo-ON line data registry. J Urol. 2008;180:554–8.

    Article  PubMed  Google Scholar 

  34. Donnelly BJ, Saliken JC, Brasher PMA, Ernst SC, Rewcastle JC, Lau H, et al. A randomized trial of external radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010;116:323–30.

    Article  CAS  PubMed  Google Scholar 

  35. Chin JL, Al-Zahrani AA, Autran-Gomez AM, Williams AK, Bauman G. Extended follow-up oncologic outcome of randomized trial between cryoablation and external beam therapy for locally advanced prostate cancer (T2a-T3b). J Urol. 2012;188:1170–5.

    Article  PubMed  Google Scholar 

  36. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr. Five-year retrospective, multi-institutional pooled analysis of cancer- related outcomes after cryoablation of the prostate. Urology. 2001;57:518–23.

    Article  CAS  PubMed  Google Scholar 

  37. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002;60:3–11.

    Article  PubMed  Google Scholar 

  38. Han KR, Cohen JK, Miller RJ, et al. Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003;170:1126–30.

    Article  PubMed  Google Scholar 

  39. Cohen JK, Miller jr RJ, Ahmed S, Lotz MJ, Baust J. Ten year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008;71:515–8.

    Article  PubMed  Google Scholar 

  40. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of salvage cryoablation of the prostate after radiation; identifying predictors of treatment failure and complications. J Urol. 2001;165:1937–41.

    Article  CAS  PubMed  Google Scholar 

  41. Ismail M, Ahmed S, Kastner C, Davies J. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of first 100 patients. BJU Int. 2007;100:760–4.

    Article  PubMed  Google Scholar 

  42. Ng CK, Moussa M, Downey DB, Chin JL. Salvage cryoablation of the prostate: follow-up and analysis of predictive factors for outcome. J Urol. 2007;178:1253–7.

    Article  PubMed  Google Scholar 

  43. Bahn DK, Lee F, Silvermann P, et al. Salvage cryotherapy for recurrent prostate cancer after radiation therapy: a seven year follow-up. Clin Prostate Cancer. 2003;2:111–4.

    Article  PubMed  Google Scholar 

  44. Prepelica KL, Okeke Z, Murphy A, Katz AE. Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer. 2005;103:1625–30.

    Article  PubMed  Google Scholar 

  45. De La Tallie A, Benson MC, Bagiella E, Burkhardt M, Shasigh A, Olsson CA, et al. Cryoablation for localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int. 2000;85:281–6.

    Article  Google Scholar 

  46. Cohen JK, Miller RJ, Shuman BA. Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995;45:861–4.

    Article  CAS  PubMed  Google Scholar 

  47. Ellis DS, Manny TB Jr, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007;69:306–10.

    Article  PubMed  Google Scholar 

  48. Wake RW, Hollabaugh RS Jr, Bond KH. Cryoablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol. 1996;155:1663–6.

    Article  CAS  PubMed  Google Scholar 

  49. Badalament RA, Bahn DK, Kim H, Kumar A, Bahn JM, Lee F. Patient-reported complications after cryoablation therapy for prostate cancer. Urology. 1999;54:295–300.

    Article  CAS  PubMed  Google Scholar 

  50. Katz AE, Preplica KL, Masson P, Benson MC, McKierman JM. Salvage cryosurgical ablation of the prostate (TCAP) for patients failing radiation: 10 year experience. J Urol. 2005;173:450. (abstract 1662)

    Article  Google Scholar 

  51. Tatsutani K, Rubinsky B, Onik GM, et al. Effect of thermal variables on frozen human primary prostatic adenocarcinoma cells. Urology. 1996;48:441–7.

    Article  CAS  PubMed  Google Scholar 

  52. Gowardhan B, Greene D. Cryotherapy for the prostate: in vitro and clinical study of two new developments; advanced cryoneedles and a temperature monitoring system. BJU Int. 2007;100:295–302.

    Article  PubMed  Google Scholar 

  53. Lee F, Bahn DK, Badalament RA, et al. Cryosurgery for prostate cancer; improved glandular ablation by use of 6–8 cryoprobes. Urology. 1999;54:135–40.

    Article  CAS  PubMed  Google Scholar 

  54. Moore Y, Sofer P. Successful treatment of locally confined prostate cancer with the seed net system: preliminary multi-center results. Clinical application notes Feb 2001. Available through Galil Medical, Haifa. 2001. http//Galilmedicalcom. Accessed 7 Nov 2001.

    Google Scholar 

  55. Onik G, Narayan P, Brunelle R, et al. Saline injection into Denonvilliers’ fascia during prostate cryosurgery. J Min Ther Relat Tech. 2009;9:423–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Joseph Babaian M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Babaian, R.J. (2018). History and Development of Prostate Cryoablation. In: Patel, S., Moran, M., Nakada, S. (eds) The History of Technologic Advancements in Urology. Springer, Cham. https://doi.org/10.1007/978-3-319-61691-9_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-61691-9_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-61689-6

  • Online ISBN: 978-3-319-61691-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics